Transcriptome based prediction of the response to neoadjuvant chemotherapy of head and neck squamous cell carcinoma

被引：0
|
作者：
Tomkiewicz, C. [1 ]
Hans, S. [1 ]
Agier, N. [1 ]
Marisa, L. [1 ]
Mucchielli-Giorgi, M. H. [1 ]
Imbeaud, S. [1 ]
Detacroix, H. [1 ]
Beaune, P. [1 ]
Laurent-Puig, P. [1 ]
Laccourreye, O. [1 ]
Brasnu, D. [1 ]
Aggerbeck, L. [1 ]
Barouki, R. [1 ]
Aggerbeck, M. [1 ]
机构：
[1] Univ Paris 05, Paris, France
来源：
ORAL ONCOLOGY | 2007年
关键词：
transcriptome; chemotherapy; resistance; oropharynx;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab plus cetuximab with neoadjuvant chemotherapy for head and neck squamous cell carcinoma
    Yao, Zhuowei
    Wang, Jingshuo
    Jiang, Yongquan
    Zhang, Yi
    Liu, Jun
    Dai, Li
    Shen, Silin
    Zhou, Xiang
    Liu, Qiang
    Zheng, Luying
    Qian, Minfei
    Li, Jiping
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024,
  • [2] Sequential neoadjuvant chemotherapy (SC) for head and neck squamous cell carcinoma (HNSCC)
    Rixe, O
    Gatineau, M
    Batouche, M
    Raymond, E
    Domenge, C
    Janot, F
    Schwaab, G
    Luboinski, B
    Armand, JP
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 175 - 175
  • [3] Survival results of neoadjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck
    Kohno, N
    Ikari, T
    Kawaida, M
    Tanaka, K
    Kawaura, M
    Kano, S
    Nakamizo, M
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (06) : 253 - 258
  • [4] Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy
    Cabelguenne, A
    Loriot, MA
    Stucker, I
    Blons, H
    Koum-Besson, E
    Brasnu, D
    Beaune, P
    Laccourreye, O
    Laurent-Puig, P
    De Waziers, I
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (05) : 725 - 730
  • [5] Neoadjuvant immunotherapy for head and neck squamous cell carcinoma
    Kuerten, Cornelius H. L.
    Ferris, Robert L.
    [J]. LARYNGO-RHINO-OTOLOGIE, 2024, 103 : S167 - S187
  • [6] Neoadjuvant Chemotherapy for Hypopharyngeal Squamous Cell Carcinoma and Personalized Medicine in Head and Neck Cancer
    Gordin, Eli
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (04) : 848 - 849
  • [7] Neoadjuvant Chemotherapy for Hypopharyngeal Squamous Cell Carcinoma and Personalized Medicine in Head and Neck Cancer
    Eli Gordin
    [J]. Annals of Surgical Oncology, 2018, 25 : 848 - 849
  • [8] Matrix metalloproteinase 3 polymorphism:: A predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma
    Blons, H
    Gad, S
    Zinzindohoué, F
    Manière, I
    Beauregard, J
    Tregouet, D
    Brasnu, D
    Beaune, P
    Laccourreye, O
    Laurent-Puig, P
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (08) : 2594 - 2599
  • [9] Multifocal regression and pathologic response predicts recurrence after neoadjuvant chemotherapy in head and neck squamous cell carcinoma
    Kiong, Kimberley L.
    Bell, Diana
    Yao, Christopher M. K. L.
    Ferrarotto, Renata
    Lewis, Carol M.
    [J]. ORAL ONCOLOGY, 2021, 122
  • [10] Biomarkers predicting chemotherapy response in head and neck squamous cell carcinoma: a review
    Cosway, B.
    Paleri, V.
    Wilson, J.
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2015, 129 (11): : 1046 - 1052
12345